As part of the STI Outlook 2016, the OECD has released policy profiles by country. These include cross-country analyses that draw on the first joint EC-OECD survey on STI policies. They focus on major STI policy areas, instruments and trends.
This publication provides detailed country notes on Value Added Tax/Goods and Services Tax (VAT/GST) and excise duty rates in OECD member countries.
This annual publication presents detailed country notes and internationally comparable tax data for all OECD countries from 1965 onwards.
English, PDF, 615kb
The number of young people not in employment, education or training (NEETs) remains elevated in many countries since the crisis. This country note examines the characteristics of those at risk of being NEET in Ireland along with policies to help meet the challenge. It also includes many new youth-specific indicators on family formation, self-sufficiency, income and poverty, health and social cohesion.
English, PDF, 512kb
This country note provides an environmental tax and carbon pricing profile for Ireland. It shows environmentally related tax revenues, taxes on energy use and effective carbon rates.
The data presented in the latest OECD Economic Survey of Ireland suggest that rather than "brain drain" Ireland exhibits "brains exchange", a large proportion of emigrants and immigrants are well qualified.
English, PDF, 382kb
Entry to medical education in Ireland can occur in two ways: students can access it directly from secondary school (in which case it takes them 5 to 6 years to complete the programme) or after receiving a first bachelor degree (in which case the programme can be completed in 4 years).
The 2015 edition introduces more detailed analysis of participation in early childhood and tertiary levels of education. The report also examines first generation tertiary-educated adults’ educational and social mobility, labour market outcomes for recent graduates, and participation in employer-sponsored formal and/or non-formal education.
English, PDF, 508kb
Although expenditure on pharmaceuticals in Ireland fell over the past few years, it still remains well above the OECD average.